February 19, 1999

7 a.m.-8:30 a.m.
Industry-Supported Symposia
IS30. Part II: Novel Approaches to the Treatment of Impulsivity Supported by Solvay Pharmaceuticals Inc.
A. Treatment for Impulsivity and Aggressivity in PTSD Charles R. Marmar, M.D.
B. The Relationship Between Bipolar Spectrum and Impulse Control Disorders Concetta M. DeCaria, Ph.D.

IS31. Part II: Mood and Psychotic Disorders in Women: An Update on Treatment Supported by Eli Lilly and Company
A. Gender and the Second Generation of Antipsychotics Ruth A. Dickson, M.D.
B. Estrogen and Mood in Perimenopausal Women Catherine A. Roca, M.D.

IS32. Part II: Anxiety Disorders: From Scientific Research to Clinical Practice Supported by U.S. Pharmaceuticals, Pfizer Inc.
A. Social Phobia: Course, Complications, and Therapeutics John H. Greist, M.D.
B. Understanding Quality of Life in Anxiety Disorders Mark H. Rapaport, M.D.
C. Applying Cognitive-Behavior Therapy to Clinical Pharmacotherapy Michael W. Otto, Ph.D.

IS33. Part II: Assessment and Treatment of Psychiatric Disorders in the Elderly Supported by Janssen Pharmaceutica and Research Foundation
A. Coping in Late Life W. Walter Menninger, M.D.
B. Early Detectioin and Comorbidity Issues: Dementia and Depression in the Elderly Stephen M. Aronson, M.D.
C. Typical Versus Atypical Antipsychotics in the Elderly Dilip V. Jeste, M.D.

IS34. Part II: Advances in the Treatment of Geriatric Depression Supported by SmithKline Beecham Pharmaceuticals
A. Treating Depression in the Older Patient With Comorbid Ischemic Disease Steven P. Roose, M.D.
B. The Current Role of ECT in the Treatment of Geriatric Depression Harold A. Sackeim, Ph.D.

7:30 a.m.-2 p.m.
Registration/Course Enrollment Open

8 a.m.-Noon
CME Courses 93-95

9 a.m.-10:30 a.m.
Lectures
L20. Hispanic Psychiatry: From Margin to Mainstream Renato D. Alarcon, M.D., APA’s Simon Bolivar Award Lecture
L21. Internist of the Mind or Doctors of the Soul? Donald S. Browning, Ph.D., APA’s Oskar Pfister Award Lecture

Master Educator Clinical Consultations
14. Frederick K. Goodwin, M.D., on The Management of Bipolar Disorder (Open to APA members only.)
15. Jack M. Gorman, M.D. (Topic to be announced.) (Open to APA members only.)

New Research Oral/Slide Sessions

Component Workshops
CW44. The Fallout From Hospital Mergers and Closings APA Committee on Physician Health, Illness, and Impairment Co-Chairpersons: Linda Logsdon, M.D., and Richard F. Limoges, M.D.
CW45. Beyond Sex: Gay Issues and the General Psychiatrist APA Committee on Gay, Lesbian, and Bisexual Issues Co-Chairpersons: Diana C. Miller, M.D., and Leslie G. Goransson, M.D.
CW46. Systems of Care for Serious Emotional Disordered Children and Adolescents APA Committee on Children With Mental or Developmental Disorders Chairperson: Carl B. Feinstein, M.D.
CW47. HIV Prevention: Stigma and Names-Based Reporting APA New York County District Branch’s AIDS Committee Chairperson: Elizabeth V. Getter, M.D.
CW48. To Tell or Not to Tell: The Impaired Supervisor APA/GlaxoWellcome Fellowship Co-Chairpersons: Clifford A. McNaughton, M.D., and Karine J. Igartua, M.D.
CW49. National Health Insurance: A District Branch View APA Psychiatric Society of Westchester County Inc. Chairperson: Timothy B. Sullivan, M.D.
CW50. Getting Your Patient on Social Security Income: An Insider’s Guide APA Committee on Poverty, Homelessness, and Psychiatric Disorders Chairperson: Stephen M. Goldfinger, M.D.

Issue Workshops
IW57. DSM-IV and Old-Time Rock and Roll Chairperson: Henry B. Nelson III, M.D.
IW58. To Live or Die: Complexities at Life’s End Chairperson: James W. Lomax II, M.D.
IW59. Treatment Resistance Versus Resistant Treaters Chairperson: Michael R. Fox, M.D.
IW60. Teaching Assessment via Role Play: A Demonstration Chairperson: Julia B. Frank, M.D.
IW61. Swimming With the Sharks: Organization Politics Chairperson: Michelle Riba, M.D.
IW62. Doctor, Learn to Set Limits and Reduce Malpractice Suits Chairperson: Miguel A. Leibovich, M.D.
IW63. Video Case Studies of Couples in Treatment Chairperson: Ian E. Alger, M.D.
IW64. Cognitive Therapy for Personality Disorders Co-Chairpersons: Judith S. Beck, Ph.D., and Jesse H. Wright, M.D.
IW65. Psychiatry and Politics Co-Chairpersons: Paul A. Kettl, M.D., and Jay B. Cutler, J.D.
IW66. Preventing Suicide: Team Building and Mobilizing Resources Chairperson: Alex N. Sabo, M.D.
IW67. Culture: Perception and Communication Co-Chairpersons: Trevia F. Hayden, M.D., and Raina T. Sullivan, M.D.
IW68. Bridging Traditions in Psychiatric Education Co-Chairpersons: Todd S. Cox, M.D., and Irving M. Reti, M.D.
IW69. Update on Mental Health in the Oregon Health Plan Co-Chairpersons: Bentson H. McFarland, M.D., and David A. Pollack, M.D.
IW70. Safeguarding the Electronic Psychiatric Record Chairperson: David P. Olson, M.D.
IW71. Toning and Chanting and Music Meet Memories Chairperson: Leah J. Dickstein, M.D.
IW72. Clinical Implications of the Cytochrome P450 Chairperson: George M. Simpson, M.D.

9 a.m.-11 a.m.
Media Session
Session 32. The Holocaust: From Ongoing Trauma to Stories of Healing
53. Silence
54. The Last Transfer
55. Three Stories

9 a.m.-4 p.m.
CME Courses 96-97

11 a.m.-12:30 p.m.
Lecture
L23. Technological Advances in Infertility Therapy: Impact on Biology and Patients Grace Couchman, M.D., Frontiers of Science Lecture Series

Master Educator Clinical Consultations
16. Katherine A. Halmi, M.D., on Anorexia and Bulimia Nervosa (Open to APA members only.)
17. Carl Eisdorfer, M.D., on Geriatric Psychiatry Patients (Open to APA members only.)

Medical Update
4. Marc E. Lippman, M.D., on Progress in the Treatment of Breast Cancer

Scientific and Clinical Report Sessions
Session 26. New Issues in Psychiatric Genetics
77. Polymorphisms in the Serotonin Transporter Gene and Cocaine Dependence Ashwin A. Patkar, M.D.
78. Serotonin Genetic Polymorphism in SAD and Bulimia Nervosa Robert D. Levitan, M.D.
79. Genetic Antecedents of Dopamine Dysfunction in Schizophrenia Farooq Amin, M.D.

Session 27. Compulsion: Eating and Gambling
80. Assessing Adolescent Perceptions of Gambling Risk James R. Westphal, M.D.
81. Long-Term Treatment of Bulimia Nervosa Following Acute Response: A Comparison of Fluoxetine and Placebo Steven J. Romano, M.D.
82. Predictors of Early Treatment Outcome in Anorexia William T. Howard, M.D.

Session 28. Clinical Risk Factors for Mental Disorders
83. Victimization as a Risk Factor for Major Depression Julio E. Arboleda-Florez, M.D.
84. Mortality and Morbidity Among Psychiatric Patients Taru H. Makikyro, M.D.
85. School Predictors of Hospital-Treated Psychiatric Disorders in the 1996 Northern Finland Birth Cohort Matti K. Isohanni, M.D.

Session 29. Risks and Management of Psychotropic Drugs
86. Serotonin Selectivity Reduces Mania Induction Yoram Barak, M.D.
87. Risperidone-Associated Dyskinesia Patricia I. Rosebush, M.D.
88. Ondansetron, a Serotonin Antagonist, Improves Tardive Dyskinesia Pinkhas Sirota, M.D.

Session 30. Antecedents and New Treatments in Schizophrenia
89. Childhood Adversity and Adult Homelessness Carol L.M. Caton, Ph.D.
90. Comparative Efficacy of Olanzapine and Haloperidol for Patients With Treatment-Resistant Schizophrenia Alan F. Breier, M.D.
91. Low-Frequency Transcranial Magnetic Stimulation in Patients Reporting Voices Ralph E. Hoffman, M.D.

Session 31. Outcome Studies in Mood Disorders
92. Psychodynamic Psychotherapy of the Suicidal Adolescent Girl Philip N. Cheifetz, M.D.
93. Bipolar Outcome: A 10-Year Follow-Up Joseph F. Goldberg, M.D.
94. Families and the Treatment of Chronic Depression Gabor I. Keitner, M.D.

Session 32. Controversies in Managed Care
95. Declining Mental Health Service Use in a Large Corporation Robert A. Rosenheck, M.D.
96. Discrimination in Utilization Management Lawrence Y. Kline, M.D.
97. Malpractice Liability and Managed Care: Developments Eugene L. Lowenkopf, M.D.

Component Workshops
CW51. Internists of the Mind or Doctors of the Soul? APA Committee on Religion and Psychiatry and APA Council on National Affairs Chairperson: William N. Grosch, M.D.
CW52. Documentation Requirements and Coding Update APA Work Group on Codes and Reimbursements and APA Work Group on Harvard Resource-Based Relative Value Scale Study Co-Chairpersons: Chester W. Schmidt Jr., M.D., and Donald J. Scherl, M.D.
CW53. Decriminalizing Severely Mentally Ill Persons APA Council on Psychiatric Services Chairperson: H. Richard Lamb, M.D.
CW54. Human Factors in Telepsychiatry APA Committee on Telemedical Services Chairperson: David F. McMahon, M.D.
CW55. Psychiatric Dimensions of Disaster APA Committee on Psychiatric Dimensions of Disasters Chairperson: Robert J. Ursano, M.D.
CW56. New APA Practice Recommendations on ECT APA Task Force on Electroconvulsive Therapy Chairperson: Richard D. Weiner, M.D.

Issue Workshops
IW73. Teaching Psychiatry in an Ambulatory Setting Chairperson: Richard Balon, M.D.
IW74. Treating the Stressed Physician Chairperson: Roy W. Menninger, M.D.
IW75. How to Make an Effective Psychiatric Presentation Chairperson: Phillip J. Resnick, M.D.
IW76. Pharmacotherapy of Addictive Disorders Co-Chairpersons: Norman S. Miller, M.D., and Raye Litten, Ph.D.
IW77. Clinical Issues in Geriatric Alcoholism Co-Chairpersons: Roland M. Atkinson, M.D., and David W. Oslin, M.D.
IW78. Assessment and Intervention of Movement Disorders Chairperson: Leonardo Cortese, M.D.
IW79. The Woman International Medical Graduate in Psychiatry Chairperson: Umadevi Naidoo, M.D.
IW80. Cognitive-Behavior Therapy of Schizophrenia Chairperson: David G. Kingdon, M.D.
IW81. Medical Savings Account Plans: Putting You and Your Patients First Chairperson: David T. Springer, M.D.
IW82. Teaching Psychotherapy in a Managed Care Setting Chairperson: James H. Scully Jr., M.D.
IW83. Medicaid Managed Care in Maryland: Expanding Access and Early Intervention for Children and Adolescents Chairperson: Albert A. Zachik, M.D.

11 a.m.-2 p.m.
Media Session
Session 33. Child Sexual Abuse: Sociocultural and Clinical Perspectives
56. Still Missing
57. Sacrifice
58. Trying to Get Some Dignity
59. Interviewing for Child Sexual Abuse

Noon-1:30 p.m.
Forums
8. Ethics and Human Rights: An International Perspective Chairperson: Rodrigo A. Muñoz, M.D.
9. The Patient Named Sybil: DID Issues Chairperson: Leah J. Dickstein, M.D.

Noon-2 p.m.
New Research Poster Session

2 p.m.-5 p.m.
Symposia
S72. Sexual Medicine: The Highlights of the Decade
A. Advances in the Sex Therapeutic Treatment of Women Barbara D. Bartlik, M.D.
B. Advances in the Treatment of Male Sexual Disorders Peter M. Kaplan, M.D.
C. Testosterone and Women’s Sexuality Susan Rako, M.D.
D. Alternative Medicines and Therapies for Sexual Dysfunction Alan J. Cohen, M.D.
E. The Therapeutic Use of Erotic Video and Sexual Aids Nina Hartley, M.D.
F. The Age of Cybersex and Its Impact on Patient Population Sharna L. Striar, Ph.D.

S73. Update on Treatment of Stimulant Abuse
A. Behavioral and Community-Based Treatment Approaches Douglas M. Ziedonis, M.D.
B. Psychotherapy and Counseling Approaches for Cocaine Abusers David R. Gastfriend, M.D.
C. Pharmacological Treatment of Stimulant Abuse David A. Gorelick, M.D.
D. Psychiatric Comorbidity in Stimulant Abusers Richard N. Rosenthal, M.D.
E. New Developments in Treating Methamphetamine Abuse Steven L. Batki, M.D.

S74. Disability Costs: Rehabilitation Opportunity? World Psychiatric Association’s Section on Rehabilitation and World Association for Psychosocial Rehabilitation
A. Disability and Mental Health Norman Sartorius, M.D.
B. Rehabilitation and Disability in Japan Naotaka Shinfuku, M.D.
C. Germany: Reconciling Policies Michael Stark, M.D.
D. France, Canada, the European Community, and the International Labor Organization Gaston P. Harnois, M.D.
E. United States: Managed Disability Care? Zebulon C. TaIntor, M.D.

S75. Alternative Therapies in Depression and Anxiety
A. Alternative Therapies in Psychiatric Outpatients Kathryn M. Connor, M.D.
B. Botanical Extracts as Anxiolytic Treatments or Adjuncts Jerry M. Cott, Ph.D.
C. Centella Asiatica Decreases the Acoustic Startle Response Jacques Bradwejn, M.D.
D. Hypericum Perforatum: Its Relevance to Psychiatric Practice Jonathan R.T. Davidson, M.D.
E. The Efficacy of Acupuncture in the Treatment of Depression John J.B. Allen, Ph.D.

S76. Model Residency Programs on Religion/Spirituality
A. The Baylor Curriculum on Religion/Spirituality and Psychiatry James W. Lomax II, M.D.
B. Psychiatry Residency Award Program at Bronx-Lebanon Hospital Nalini V. Juthani, M.D.
C. The Jefferson Medical College Curriculum on Religion/Spirituality and Psychiatry Shimon Waldfogel, M.D.
D. Residency Training on Religion/Spirituality at Loma Linda University School of Medicine Donald L. Anderson, M.D.
E. Functions of Faith: A Framework for Therapy at the University of Pittsburgh Carl A. Jensen, D.M.N.
F. Training Programs on Spirituality at California Pacific Medical Center and the University of California at San Francisco Elizabeth F. Targ, M.D.
G. Spirituality and Religion in the Harvard Longwood Residency John R. Peteet, M.D.

S77. Managed Care Versus Fee-for-Service Medicaid for Adults With Severe Mental Illness
A. Medicaid Managed Mental Health Care: Overview A. Michael Wylie, Ph.D.
B. Managed Care Systems in Adult Medicaid Clients With Severe Mental Illness in Five States David L. Shern, Ph.D.
C. Service Use by Mentally Ill Persons in Managed Care Aileen Rothbard, Sc.D.
D. Outcomes for Medicaid Beneficiaries in Managed Care Versus Fee for Service Bentson H. McFarland, M.D.

S78. New Insights Into Dementia
A. Genetics of Alzheimer’s Disease Gary W. Small, M.D.
B. Psychosis and Agitation in Dementia Dilip V. Jeste, M.D.
C. Mechanisms of Depression in Dementia George S. Alexopoulos, M.D.
D. Cognitive Enhancers Lon S. Schneider, M.D.
E. Behavioral Interventions in Dementia Care Soo Borson, M.D.

S79. Suicidality: Diagnosis and Treatment
A. Evaluation of Suicide Risk in a Time of Managed Care Richard C.W. Hall, M.D.
B. Management of Suicidality in Patients With BPD Michael H. Stone, M.D.
C. Chronic Suicidality: A Life and Death Project Roger A. Lewin, M.D.
D. Assessing Adolescent Suicide Risk Cynthia R. Pfeffer, M.D.

S80. Updates on the Textbook of Psychopharmacology
A. Update on Neuroendocrine Alterations in Psychiatric Illnesses Ned H. Kalin, M.D.
B. Depression and Cardiovascular Disease Charles B. Nemeroff, M.D.
C. Pharmacologic Treatment in Childhood Psychiatric Disorders Elizabeth B. Weller, M.D.
D. Overview of SSRIs Jerrold F. Rosenbaum, M.D.
E. Updates on Antiepileptic Drugs in Bipolar Disorder Susan L. McElroy, M.D.

S81. Telepsychiatry: Why Do It? APA Committee on Telemedical Services
A. Telepsychiatry: Why Bother? Ellen N. Rothchild, M.D.
B. Telepsychiatry for Fun and Profit Charles L. Zaylor, D.O.
C. Successful Use of Telepsychiatry to Link the Academic Health System With the Primary Care Setting Donald M. Hilty, M.D.
D. Child Telepsychiatry Clinics David J. Ermer, M.D.
E. Telepsychiatry in Geriatric Populations Beverly N. Jones, M.D.
F. Use of Telepsychiatry in Forensic Settings Philip T. Merideth, M.D.
G. Telemedicine and Distance Learning Charles L. Zaylor, D.O.

S82. Defining Personality in the 21st Century
A. A Psychobiological Approach to Personality C. Robert Cloninger, M.D.
B. Defense Mechanisms and Axis I: An Empirical Search for Stability Linda S. Mullen, M.D.
C. Phenomenology of BPD Mary C. Zanarini, Ed.D.
D. Can Medication Change Personality? Carlos Blanco-Jerez, M.D.

S83. When Your Patient Suicides and You Are a Resident
A. Case Presentation and Phenomenology of Suicide Peter Betz, M.D.
B. Psychological Vulnerabilities in Psychiatric Residents James W. Ethier, M.D.
C. In the Darkest Hour: The Residency Program Responds Edward A. Minor, M.D.
D. Resident’s Patient Commits Suicide: Legal Liability Vani A. Rao, M.D.

S84. Cultural Identity and Mental Health
A. Bicultural Identification and Its Multi-Ethnic Validation Juan E. Mezzich, M.D.
B. Cultural Identity and Mental Health: Asian-American Perspectives Keh-Ming Lin, M.D.
C. Alienation and Mental Health: African-American Viewpoints Carl C. Bell, M.D.
D. Bicultural Issues in Geneva Ariel Eytan, M.D.
E. Immigration, Culture, and Mental Health in Israel Yair C. Bar-El, M.D.

S85. Psychiatric Issues in Desire for Death
A. Desire for Death Among Cancer and AIDS Patients William Breitbart, M.D.
B. Coping Style, Depression, and Group Therapy in Terminal Illness David Spiegel, M.D.
C. Treating Terminally Ill Patients With HIV Robert L. Klitzman, M.D.
D. Desire for Hastened Death in End-Stage AIDS Disease Susan Folkman, Ph.D.

S86. Improving Early Psychosis Outcomes in Canada
A. The Effect of Perinatal Events on Outcome in Early Psychosis Lili C. Kopala, M.D.
B. Neurocognitive Outcomes in Early Psychosis Jean M. Addington, Ph.D.
C. Population-Based Programs: Process and Outcome Indicators Donald E. Addington, M.D.
D. Outcome in a First-Episode Psychosis Cohort Ashok K. Malla, M.D.
E. Pharmacologic Strategies for First-Episode Psychosis Robert B. Zipursky, M.D.

S87. The Psychopharmacology of Severe Mental Disorders Collaborative Session With the National Institute of Mental Health
A. New Antipsychotics: Data and Methods John M. Kane, M.D.
B. Advances in the Treatment of Childbearing Katherine L. Wisner, M.D.
C. Mood Stabilizers and Signal Transduction Regulation Husseini K. Manji, M.D.
D. Antipsychotics in Child and Adolescent Psychiatry Robert J. Nicolson, M.D.
E. Isozyme-Specific Drug Metabolism in the Elderly Bruce G. Pollock, M.D.

S88. Psychiatry and Crime Victims: Bridging the Gap U.S. Department of Justice’s Office for Victims of Crime, APA Task Force on Violence, and APA Committee on Family Violence and Sex Abuse
A. Crime Victimization and Psychiatric Disorders: Epidemiology Timothy D. Brewerton, M.D.
B. Crime Victim Compensation Program Directory Dan M. Eddy, J.D.
C. The Philadelphia Youth Homicide Committee Paul Jay Fink, M.D.
D. Generational Transmission of Victimization in Child Abuse Arthur H. Green, M.D.
E. A Support Project for Homicide Edward K. Rynearson, M.D.
F. Overview of Research on Effects of Crime Victimization on Mental Health Deborah Spungen, M.S.S.
G. Pennsylvania Coalition Against Rape B .J. Horn

S89. Advanced Risk Management Issues and Strategies
A. Risk Management in Child and Adolescent Psychopharmacology Diane H. Schetky, M.D.
B. Risk Management and the Dual-Diagnosis Patient Patricia R. Recupero, M.D.
C. Risk Management and Managed Care Paul S. Appelbaum, M.D.
D. Risk Management Issues With Incarcerated Patients Jeffrey L. Metzner, M.D.
E. Advanced Risk Management Issues and Strategies Renee L. Binder, M.D.

S90. Beyond Imaging: MR Scanning in Psychiatry
A. Clinical Pharmacology by MR Scanning Bruce M. Cohen, M.D.
B. Panic Disorder: MR Studies of Cause and Treatment Stephen R. Dager, M.D.
C. Functional MRI in Schizophrenia: Effects of Treatment on Regional Activation Deborah A. Yurgelun-Todd, Ph.D.
D. MR Studies of Drug Abuse Perry F. Renshaw, M.D.

S91. The Treatment of Depression in Women
A. Biological Basis for Gender Differences in Depression Philip W. Gold, M.D.
B. Premenstrual Dsyphoric Disorder Barbara L. Parry, M.D.
C. Pharmacologic Management of Depression During Pregnancy and Postpartum Lori L. Altshuler, M.D.
D. Gonadal Steroids and Perimenopausal Depression David R. Rubinow, M.D.
E. Depressed Grandmothers, Mothers and Children Myrna M. Weissman, Ph.D.

S92. Diagnostic Issues in the 21st Century: Issues for DSM-V APA Committee on Psychiatric Diagnosis and Assessment
A. The Role of Laboratory Testing in Psychiatric Practice K. Ranga R. Krishnan, M.D.
B. The Definition of Mental Disorder Revised Jerome Wakefield, M.D.
C. Should the Diagnostic Groupings Be Reorganized? Katharine A. Phillips, M.D.
D. Diagnostic Dilemmas in Child Psychiatry David Shaffer, M.D.
E. Personality Disorders: Clinical Utility of Classification Approaches John Livesley, M.D.

S93. The Dream 100 Years Later: New Facts, New Theories
A. Dreaming and Emotion: A New Theory Ernest L. Hartmann, M.D.
B. The Dreaming Brain Reconsidered Mark L. Solms, Ph.D.
C. New Methods for Studying Dream Content G. William Domhoff, Ph.D.
D. The Role of Dreams in Mood Regulation Rosalind Cartwright, Ph.D.

S94. Drug-Induced Disease: What Every Psychiatrist Needs to Know Food and Drug Administration
A. Premarketing Drug Safety Evaluation: What Goes Into the Label? Thomas P. Laughren, M.D.
B. Drug-Induced Disease: Pharmacokinetic and Pharmacodynamic Considerations Charles J. Ganley, M.D.
C. Clinical Assessment, Work-Up, and Reporting of Adverse Drug Events Stephen A. Goldman, M.D.